VGHAX Holdings List

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	10.39%	4,794,199
2	LON: AZN	AstraZeneca PLC	6.26%	16,181,104
3	UNH	UnitedHealth Group Incorporated	5.36%	6,178,065
4	MRK	Merck & Co., Inc.	4.36%	19,801,465
5	BSX	Boston Scientific Corporation	4.19%	14,035,501
6	VRTX	Vertex Pharmaceuticals Incorporated	3.52%	2,842,893
7	ISRG	Intuitive Surgical, Inc.	2.70%	1,786,420
8	DHR	Danaher Corporation	2.67%	4,854,515
9	CPH: NOVO.B	Novo Nordisk A/S	2.57%	13,332,193
10	ABT	Abbott Laboratories	2.46%	6,501,394
11	EW	Edwards Lifesciences Corporation	2.43%	11,192,693
12	EBR: ARGX	argenx SE	2.42%	1,572,872
13	BMY	Bristol-Myers Squibb Company	2.22%	17,248,970
14	EBR: UCB	UCB SA	2.06%	3,758,402
15	JNJ	Johnson & Johnson	1.98%	4,660,244
16	SWX: NOVN	Novartis AG	1.96%	5,819,678
17	COR	Cencora, Inc.	1.90%	2,279,215
18	LON: GSK	GSK plc	1.85%	34,960,852
19	ELV	Elevance Health, Inc.	1.84%	1,700,286
20	SWX: GALD	Galderma Group AG	1.57%	3,875,988
21	TYO: 4568	Daiichi Sankyo Company, Limited	1.55%	24,138,697
22	BIIB	Biogen Inc.	1.52%	4,367,085
23	SWX: ROG	Roche Holding AG	1.52%	1,677,044
24	GILD	Gilead Sciences, Inc.	1.49%	4,823,087
25	ALNY	Alnylam Pharmaceuticals, Inc.	1.45%	1,603,352

As of Jun 30, 2025

Showing 25 of 119 holdings

Subscribe to see the full list

Asset Allocation

Asset Class	% Weight
Stocks	98.18%
Cash	1.82%